You just read:

Spotlight Innovation's Newly Established Subsidiary Caretta Therapeutics Enters into Exclusive Licensing Agreement to Develop and Commercialize Analgesic Products

News provided by

Spotlight Innovation Inc.

06 Oct, 2016, 09:50 ET